TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

  1. Home
  2. purchase Customization

purchase customization

Leave This Empty:

choose chapter to purchase


Back to Report

table of content

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Pharmaceutical CDMO Solution
1.2 Key Market Segments
1.2.1 Pharmaceutical CDMO Solution Segment by Type
1.2.2 Pharmaceutical CDMO Solution Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Pharmaceutical CDMO Solution Market Overview
2.1 Global Market Overview
2.1.1 Global Pharmaceutical CDMO Solution Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Pharmaceutical CDMO Solution Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Pharmaceutical CDMO Solution Market Competitive Landscape
3.1 Global Pharmaceutical CDMO Solution Sales by Manufacturers (2019-2025)
3.2 Global Pharmaceutical CDMO Solution Revenue Market Share by Manufacturers (2019-2025)
3.3 Pharmaceutical CDMO Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Pharmaceutical CDMO Solution Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Pharmaceutical CDMO Solution Sales Sites, Area Served, Product Type
3.6 Pharmaceutical CDMO Solution Market Competitive Situation and Trends
3.6.1 Pharmaceutical CDMO Solution Market Concentration Rate
3.6.2 Global 5 and 10 Largest Pharmaceutical CDMO Solution Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Pharmaceutical CDMO Solution Industry Chain Analysis
4.1 Pharmaceutical CDMO Solution Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Pharmaceutical CDMO Solution Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Pharmaceutical CDMO Solution Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pharmaceutical CDMO Solution Sales Market Share by Type (2019-2025)
6.3 Global Pharmaceutical CDMO Solution Market Size Market Share by Type (2019-2025)
6.4 Global Pharmaceutical CDMO Solution Price by Type (2019-2025)
7 Pharmaceutical CDMO Solution Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pharmaceutical CDMO Solution Market Sales by Application (2019-2025)
7.3 Global Pharmaceutical CDMO Solution Market Size (M USD) by Application (2019-2025)
7.4 Global Pharmaceutical CDMO Solution Sales Growth Rate by Application (2019-2025)
8 Pharmaceutical CDMO Solution Market Consumption by Region
8.1 Global Pharmaceutical CDMO Solution Sales by Region
8.1.1 Global Pharmaceutical CDMO Solution Sales by Region
8.1.2 Global Pharmaceutical CDMO Solution Sales Market Share by Region
8.2 North America
8.2.1 North America Pharmaceutical CDMO Solution Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Pharmaceutical CDMO Solution Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Pharmaceutical CDMO Solution Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Pharmaceutical CDMO Solution Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Pharmaceutical CDMO Solution Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Pharmaceutical CDMO Solution Market Production by Region
9.1 Global Production of Pharmaceutical CDMO Solution by Region (2019-2025)
9.2 Global Pharmaceutical CDMO Solution Revenue Market Share by Region (2019-2025)
9.3 Global Pharmaceutical CDMO Solution Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Pharmaceutical CDMO Solution Production
9.4.1 North America Pharmaceutical CDMO Solution Production Growth Rate (2019-2025)
9.4.2 North America Pharmaceutical CDMO Solution Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Pharmaceutical CDMO Solution Production
9.5.1 Europe Pharmaceutical CDMO Solution Production Growth Rate (2019-2025)
9.5.2 Europe Pharmaceutical CDMO Solution Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Pharmaceutical CDMO Solution Production (2019-2025)
9.6.1 Japan Pharmaceutical CDMO Solution Production Growth Rate (2019-2025)
9.6.2 Japan Pharmaceutical CDMO Solution Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Pharmaceutical CDMO Solution Production (2019-2025)
9.7.1 China Pharmaceutical CDMO Solution Production Growth Rate (2019-2025)
9.7.2 China Pharmaceutical CDMO Solution Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Recipharm AB
10.1.1 Recipharm AB Pharmaceutical CDMO Solution Basic Information
10.1.2 Recipharm AB Pharmaceutical CDMO Solution Product Overview
10.1.3 Recipharm AB Pharmaceutical CDMO Solution Product Market Performance
10.1.4 Recipharm AB Business Overview
10.1.5 Recipharm AB Pharmaceutical CDMO Solution SWOT Analysis
10.1.6 Recipharm AB Recent Developments
10.2 Lonza Group
10.2.1 Lonza Group Pharmaceutical CDMO Solution Basic Information
10.2.2 Lonza Group Pharmaceutical CDMO Solution Product Overview
10.2.3 Lonza Group Pharmaceutical CDMO Solution Product Market Performance
10.2.4 Lonza Group Business Overview
10.2.5 Lonza Group Pharmaceutical CDMO Solution SWOT Analysis
10.2.6 Lonza Group Recent Developments
10.3 Catalent
10.3.1 Catalent Pharmaceutical CDMO Solution Basic Information
10.3.2 Catalent Pharmaceutical CDMO Solution Product Overview
10.3.3 Catalent Pharmaceutical CDMO Solution Product Market Performance
10.3.4 Catalent Pharmaceutical CDMO Solution SWOT Analysis
10.3.5 Catalent Business Overview
10.3.6 Catalent Recent Developments
10.4 Patheon (Thermo Fisher Scientific)
10.4.1 Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Solution Basic Information
10.4.2 Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Solution Product Overview
10.4.3 Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Solution Product Market Performance
10.4.4 Patheon (Thermo Fisher Scientific) Business Overview
10.4.5 Patheon (Thermo Fisher Scientific) Recent Developments
10.5 Siegfried AG
10.5.1 Siegfried AG Pharmaceutical CDMO Solution Basic Information
10.5.2 Siegfried AG Pharmaceutical CDMO Solution Product Overview
10.5.3 Siegfried AG Pharmaceutical CDMO Solution Product Market Performance
10.5.4 Siegfried AG Business Overview
10.5.5 Siegfried AG Recent Developments
10.6 SGS Quay Pharmaceuticals
10.6.1 SGS Quay Pharmaceuticals Pharmaceutical CDMO Solution Basic Information
10.6.2 SGS Quay Pharmaceuticals Pharmaceutical CDMO Solution Product Overview
10.6.3 SGS Quay Pharmaceuticals Pharmaceutical CDMO Solution Product Market Performance
10.6.4 SGS Quay Pharmaceuticals Business Overview
10.6.5 SGS Quay Pharmaceuticals Recent Developments
10.7 Curia
10.7.1 Curia Pharmaceutical CDMO Solution Basic Information
10.7.2 Curia Pharmaceutical CDMO Solution Product Overview
10.7.3 Curia Pharmaceutical CDMO Solution Product Market Performance
10.7.4 Curia Business Overview
10.7.5 Curia Recent Developments
10.8 Thermo Fisher Scientific
10.8.1 Thermo Fisher Scientific Pharmaceutical CDMO Solution Basic Information
10.8.2 Thermo Fisher Scientific Pharmaceutical CDMO Solution Product Overview
10.8.3 Thermo Fisher Scientific Pharmaceutical CDMO Solution Product Market Performance
10.8.4 Thermo Fisher Scientific Business Overview
10.8.5 Thermo Fisher Scientific Recent Developments
10.9 Samsung Biologics
10.9.1 Samsung Biologics Pharmaceutical CDMO Solution Basic Information
10.9.2 Samsung Biologics Pharmaceutical CDMO Solution Product Overview
10.9.3 Samsung Biologics Pharmaceutical CDMO Solution Product Market Performance
10.9.4 Samsung Biologics Business Overview
10.9.5 Samsung Biologics Recent Developments
10.10 Fujifilm Diosynth Biotechnologies
10.10.1 Fujifilm Diosynth Biotechnologies Pharmaceutical CDMO Solution Basic Information
10.10.2 Fujifilm Diosynth Biotechnologies Pharmaceutical CDMO Solution Product Overview
10.10.3 Fujifilm Diosynth Biotechnologies Pharmaceutical CDMO Solution Product Market Performance
10.10.4 Fujifilm Diosynth Biotechnologies Business Overview
10.10.5 Fujifilm Diosynth Biotechnologies Recent Developments
10.11 Societal CDMO
10.11.1 Societal CDMO Pharmaceutical CDMO Solution Basic Information
10.11.2 Societal CDMO Pharmaceutical CDMO Solution Product Overview
10.11.3 Societal CDMO Pharmaceutical CDMO Solution Product Market Performance
10.11.4 Societal CDMO Business Overview
10.11.5 Societal CDMO Recent Developments
10.12 Aenova Group
10.12.1 Aenova Group Pharmaceutical CDMO Solution Basic Information
10.12.2 Aenova Group Pharmaceutical CDMO Solution Product Overview
10.12.3 Aenova Group Pharmaceutical CDMO Solution Product Market Performance
10.12.4 Aenova Group Business Overview
10.12.5 Aenova Group Recent Developments
10.13 Eurofins CDMO
10.13.1 Eurofins CDMO Pharmaceutical CDMO Solution Basic Information
10.13.2 Eurofins CDMO Pharmaceutical CDMO Solution Product Overview
10.13.3 Eurofins CDMO Pharmaceutical CDMO Solution Product Market Performance
10.13.4 Eurofins CDMO Business Overview
10.13.5 Eurofins CDMO Recent Developments
10.14 Piramal Group
10.14.1 Piramal Group Pharmaceutical CDMO Solution Basic Information
10.14.2 Piramal Group Pharmaceutical CDMO Solution Product Overview
10.14.3 Piramal Group Pharmaceutical CDMO Solution Product Market Performance
10.14.4 Piramal Group Business Overview
10.14.5 Piramal Group Recent Developments
10.15 WuXi AppTec Group
10.15.1 WuXi AppTec Group Pharmaceutical CDMO Solution Basic Information
10.15.2 WuXi AppTec Group Pharmaceutical CDMO Solution Product Overview
10.15.3 WuXi AppTec Group Pharmaceutical CDMO Solution Product Market Performance
10.15.4 WuXi AppTec Group Business Overview
10.15.5 WuXi AppTec Group Recent Developments
10.16 Fareva
10.16.1 Fareva Pharmaceutical CDMO Solution Basic Information
10.16.2 Fareva Pharmaceutical CDMO Solution Product Overview
10.16.3 Fareva Pharmaceutical CDMO Solution Product Market Performance
10.16.4 Fareva Business Overview
10.16.5 Fareva Recent Developments
10.17 Strides Pharma Science
10.17.1 Strides Pharma Science Pharmaceutical CDMO Solution Basic Information
10.17.2 Strides Pharma Science Pharmaceutical CDMO Solution Product Overview
10.17.3 Strides Pharma Science Pharmaceutical CDMO Solution Product Market Performance
10.17.4 Strides Pharma Science Business Overview
10.17.5 Strides Pharma Science Recent Developments
10.18 Famar Health Care Service
10.18.1 Famar Health Care Service Pharmaceutical CDMO Solution Basic Information
10.18.2 Famar Health Care Service Pharmaceutical CDMO Solution Product Overview
10.18.3 Famar Health Care Service Pharmaceutical CDMO Solution Product Market Performance
10.18.4 Famar Health Care Service Business Overview
10.18.5 Famar Health Care Service Recent Developments
10.19 WuXi Biologics
10.19.1 WuXi Biologics Pharmaceutical CDMO Solution Basic Information
10.19.2 WuXi Biologics Pharmaceutical CDMO Solution Product Overview
10.19.3 WuXi Biologics Pharmaceutical CDMO Solution Product Market Performance
10.19.4 WuXi Biologics Business Overview
10.19.5 WuXi Biologics Recent Developments
10.20 Asymchem
10.20.1 Asymchem Pharmaceutical CDMO Solution Basic Information
10.20.2 Asymchem Pharmaceutical CDMO Solution Product Overview
10.20.3 Asymchem Pharmaceutical CDMO Solution Product Market Performance
10.20.4 Asymchem Business Overview
10.20.5 Asymchem Recent Developments
10.21 Pfizer CentreOne
10.21.1 Pfizer CentreOne Pharmaceutical CDMO Solution Basic Information
10.21.2 Pfizer CentreOne Pharmaceutical CDMO Solution Product Overview
10.21.3 Pfizer CentreOne Pharmaceutical CDMO Solution Product Market Performance
10.21.4 Pfizer CentreOne Business Overview
10.21.5 Pfizer CentreOne Recent Developments
11 Pharmaceutical CDMO Solution Market Forecast by Region
11.1 Global Pharmaceutical CDMO Solution Market Size Forecast
11.2 Global Pharmaceutical CDMO Solution Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Pharmaceutical CDMO Solution Market Size Forecast by Country
11.2.3 Asia Pacific Pharmaceutical CDMO Solution Market Size Forecast by Region
11.2.4 South America Pharmaceutical CDMO Solution Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Pharmaceutical CDMO Solution by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Pharmaceutical CDMO Solution Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Pharmaceutical CDMO Solution by Type (2025-2032)
12.1.2 Global Pharmaceutical CDMO Solution Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Pharmaceutical CDMO Solution by Type (2025-2032)
12.2 Global Pharmaceutical CDMO Solution Market Forecast by Application (2025-2032)
12.2.1 Global Pharmaceutical CDMO Solution Sales (K Units) Forecast by Application
12.2.2 Global Pharmaceutical CDMO Solution Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings